ROMIDEPSIN
Generic: ROMIDEPSIN
Amneal Pharmaceuticals LLCManufacturer
INTRAVENOUSRoute
ROMIDEPSINActive Substance
2026-06-02Original Approval
ROMIDEPSIN is FDA application ANDA219099, sponsored by AMNEAL. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INEFFECTIVE
77 reports
2
NAUSEA
55 reports
3
ELECTROCARDIOGRAM QT PROLONGED
50 reports
4
PYREXIA
50 reports
5
THROMBOCYTOPENIA
47 reports
6
DISEASE PROGRESSION
46 reports
7
FATIGUE
40 reports
8
ANAEMIA
37 reports
9
FEBRILE NEUTROPENIA
37 reports
10
OFF LABEL USE
36 reports